Literature DB >> 494159

Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma.

L O Andersson, T W Barrowcliffe, E Holmer, E A Johnson, G Söderström.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 494159     DOI： 10.1016/0049-3848(79)90159-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  19 in total

1.  Unfractionated heparin is the heparin of choice in the management of patients with acute coronary syndromes.

Authors:  S M Jafri
Journal:  J Thromb Thrombolysis       Date:  2000-02       Impact factor: 2.300

2.  In vitro anti-influenza virus activities of sulfated polysaccharide fractions from Gracilaria lemaneiformis.

Authors:  Mei-Zhen Chen; Hao-Gui Xie; La-Wei Yang; Zao-Hui Liao; Jie Yu
Journal:  Virol Sin       Date:  2010-10-08       Impact factor: 4.327

Review 3.  Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development.

Authors:  Daniel Radke; Wenkai Jia; Dhavan Sharma; Kemin Fena; Guifang Wang; Jeremy Goldman; Feng Zhao
Journal:  Adv Healthc Mater       Date:  2018-05-07       Impact factor: 9.933

4.  Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.

Authors:  P Andrade-Gordon; S Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 5.  Developments in antithrombotic therapy: state of the art anno 1996.

Authors:  H ten Cate; M T Nurmohamed; J W ten Cate
Journal:  Pharm World Sci       Date:  1996-12

Review 6.  Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.

Authors:  R Davis; D Faulds
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

7.  Binding to antithrombin of heparin fractions with different molecular weights.

Authors:  A Danielsson; I Björk
Journal:  Biochem J       Date:  1981-02-01       Impact factor: 3.857

8.  The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.

Authors:  E Holmer; K Kurachi; G Söderström
Journal:  Biochem J       Date:  1981-02-01       Impact factor: 3.857

9.  Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin.

Authors:  G F Handeland; U Abildgaard; H A Holm; K E Arnesen
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

10.  The relative molecular mass dependence of the anti-factor Xa properties of heparin.

Authors:  V Ellis; M F Scully; V V Kakkar
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.